Pancreatic Cancer Research

ResearcherKyushu UniversityNo recent work listed

Hiroshi Kono

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6843-0814; OpenAlex author ID A5101753008. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
27
Papers, trials and grants by year

2013: 4 papers · 2014: 3 papers · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper

Papers 13

  1. Predictors of the therapeutic effect of Nab-paclitaxel plus gemcitabine therapy for patients with recurrent pancreatic cancer after pancreatectomy Co-author DOI 10.21203/rs.3.rs-3201226/v1↗
  2. Cytoglobin as a Prognostic Factor for Pancreatic Ductal Adenocarcinoma: A Retrospective Analysis of 75 Patients. Co-author DOI 10.1097/mpa.0000000000001871↗
  3. Exposure to Blood Components and Inflammation Contribute to Pancreatic Cancer Progression. Co-author DOI 10.1245/s10434-021-10250-4↗
  4. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000001371↗
  5. Expression of podoplanin in stromal fibroblasts plays a pivotal role in the prognosis of patients with pancreatic cancer. First author DOI 10.1007/s00595-017-1559-x↗
  6. Feasibility of Combination Therapy with Nab-paclitaxel Plus Gemcitabine in Patients with Recurrent Pancreatic Cancer. First author DOI 10.21873/anticanres.13019↗
  7. Role of ERCP in the era of EUS-FNA for preoperative cytological confirmation of resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00595-014-0845-0↗
  8. Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary m… Co-author DOI 10.1016/j.surg.2013.06.059↗
  9. Profiling of autoantibodies in sera of pancreatic cancer patients. Co-author DOI 10.1245/s10434-014-3574-0↗
  10. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm … Co-author DOI 10.1007/s00534-012-0541-7↗
  11. A minimally invasive and simple screening test for detection of pancreatic ductal adenocarcinoma using biomarkers in duodenal juice. Co-author DOI 10.1097/mpa.0b013e3182649979↗
  12. Combination therapy of portal vein resection and adjuvant gemcitabine improved prognosis of advanced pancreatic cancer. Co-author DOI 10.1016/j.jss.2011.11.714↗
  13. Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal pa… Co-author DOI 10.6092/1590-8577/1494↗

Closest collaborators

The 25 strongest of 27 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daisuke Ichikawa · 5 shared papers, 2018–2023 · strength 0.52
  2. Hiromichi Kawaida · 5 shared papers, 2018–2023 · strength 0.52
  3. Shinichi Takano · 3 shared papers, 2018–2023 · strength 0.28
  4. Ryo Saito · 2 shared papers, 2021–2023 · strength 0.25
  5. Takao Ohtsuka · 7 shared papers, 2013–2014 · strength 0.24
  6. Masao Tanaka · 7 shared papers, 2013–2014 · strength 0.24
  7. Satoshi Kawakami · 2 shared papers, 2019–2023 · strength 0.22
  8. Nobuyuki Enomoto · 2 shared papers, 2019–2023 · strength 0.22
  9. Noboru Ideno · 6 shared papers, 2013–2014 · strength 0.20
  10. Hideki Fujii · 2 shared papers, 2018–2023 · strength 0.20
  11. Yasuhisa Mori · 5 shared papers, 2013–2014 · strength 0.17
  12. Yosuke Nagayoshi · 5 shared papers, 2013–2014 · strength 0.17
  13. Yoshinao Oda · 4 shared papers, 2013–2014 · strength 0.14
  14. Masafumi Nakamura · 4 shared papers, 2013–2014 · strength 0.13
  15. Junji Ueda · 3 shared papers, 2013–2014 · strength 0.10
  16. Koji Tamura · 3 shared papers, 2013–2014 · strength 0.10
  17. Kazuyoshi Hirayama · 1 shared paper, 2018 · strength 0.09
  18. Hideki Fujii · 1 shared paper, 2018 · strength 0.09
  19. Makoto Kadokura · 1 shared paper, 2019 · strength 0.08
  20. Hisato Igarashi · 2 shared papers, 2013–2014 · strength 0.07
  21. Shintaro Ichikawa · 1 shared paper, 2018 · strength 0.06
  22. Tadashi Kayashima · 1 shared paper, 2013 · strength 0.04
  23. Akira Aso · 1 shared paper, 2014 · strength 0.03
  24. Shingo Kozono · 1 shared paper, 2013 · strength 0.03
  25. Kenoki Ohuchida · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.